https://www.selleckchem.com/pr....oducts/eidd-2801.htm
Moreover, bleomycin was found to activate VEGF/Src signaling which increased PMCs permeability. In vivo, inhibition of VEGF/Src signaling prevented bleomycin-induced subpleural pulmonary fibrosis. At last, activation of VEGF/Src signaling was confirmed in subpleural area in patients with IPF. Taken together, our findings indicate that VEGF/Src signaling mediated pleural barrier damage and increased permeability which contributes to subpleural pulmonary fibrosis.Background One third of primary prevention implantable cardioverter-defibr
লাইক
মন্তব্য করুন
শেয়ার করুন
